位置:首页 > 蛋白库 > DHA_MYCS2
DHA_MYCS2
ID   DHA_MYCS2               Reviewed;         371 AA.
AC   A0QVQ8; Q8KY18;
DT   31-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 1.
DT   03-AUG-2022, entry version 95.
DE   RecName: Full=Alanine dehydrogenase {ECO:0000303|PubMed:12193615, ECO:0000303|PubMed:9785446};
DE            EC=1.4.1.1 {ECO:0000269|PubMed:12193615, ECO:0000269|PubMed:9785446};
GN   Name=ald {ECO:0000303|PubMed:12193615};
GN   OrderedLocusNames=MSMEG_2659, MSMEI_2596;
OS   Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) (Mycobacterium
OS   smegmatis).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycolicibacterium.
OX   NCBI_TaxID=246196;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 1-10, FUNCTION,
RP   CATALYTIC ACTIVITY, INDUCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=12193615; DOI=10.1128/jb.184.18.5001-5010.2002;
RA   Feng Z., Caceres N.E., Sarath G., Barletta R.G.;
RT   "Mycobacterium smegmatis L-alanine dehydrogenase (Ald) is required for
RT   proficient utilization of alanine as a sole nitrogen source and sustained
RT   anaerobic growth.";
RL   J. Bacteriol. 184:5001-5010(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RA   Fleischmann R.D., Dodson R.J., Haft D.H., Merkel J.S., Nelson W.C.,
RA   Fraser C.M.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=17295914; DOI=10.1186/gb-2007-8-2-r20;
RA   Deshayes C., Perrodou E., Gallien S., Euphrasie D., Schaeffer C.,
RA   Van-Dorsselaer A., Poch O., Lecompte O., Reyrat J.-M.;
RT   "Interrupted coding sequences in Mycobacterium smegmatis: authentic
RT   mutations or sequencing errors?";
RL   Genome Biol. 8:R20.1-R20.9(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700084 / mc(2)155;
RX   PubMed=18955433; DOI=10.1101/gr.081901.108;
RA   Gallien S., Perrodou E., Carapito C., Deshayes C., Reyrat J.-M.,
RA   Van Dorsselaer A., Poch O., Schaeffer C., Lecompte O.;
RT   "Ortho-proteogenomics: multiple proteomes investigation through orthology
RT   and a new MS-based protocol.";
RL   Genome Res. 19:128-135(2009).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, INDUCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9785446; DOI=10.1111/j.1574-6968.1998.tb13200.x;
RA   Hutter B., Dick T.;
RT   "Increased alanine dehydrogenase activity during dormancy in Mycobacterium
RT   smegmatis.";
RL   FEMS Microbiol. Lett. 167:7-11(1998).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9493394; DOI=10.1099/00221287-144-2-577;
RA   Raynaud C., Etienne G., Peyron P., Laneelle M.A., Daffe M.;
RT   "Extracellular enzyme activities potentially involved in the pathogenicity
RT   of Mycobacterium tuberculosis.";
RL   Microbiology 144:577-587(1998).
CC   -!- FUNCTION: Catalyzes the reversible reductive amination of pyruvate to
CC       L-alanine. Required for proficient utilization of D- or L-alanine as a
CC       nitrogen source. May be required for the adaptation from aerobic growth
CC       to anaerobic dormancy. It could be involved in the maintenance of the
CC       NAD pool during the shift to an anaerobic dormant state in which oxygen
CC       as a terminal electron acceptor becomes limiting.
CC       {ECO:0000269|PubMed:12193615, ECO:0000269|PubMed:9785446}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-alanine + NAD(+) = H(+) + NADH + NH4(+) + pyruvate;
CC         Xref=Rhea:RHEA:18405, ChEBI:CHEBI:15361, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:28938, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:57972; EC=1.4.1.1;
CC         Evidence={ECO:0000269|PubMed:12193615, ECO:0000269|PubMed:9785446};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is between 10 and 11 for the oxidative deamination and
CC         between 7 and 7.5 for the reductive amination.
CC         {ECO:0000269|PubMed:9785446};
CC   -!- PATHWAY: Amino-acid degradation; L-alanine degradation via
CC       dehydrogenase pathway; NH(3) and pyruvate from L-alanine: step 1/1.
CC   -!- SUBUNIT: Homohexamer. Trimer of dimers. {ECO:0000250|UniProtKB:P9WQB1}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9493394}.
CC   -!- INDUCTION: Induced by both D- and L-alanine under aerobic and anaerobic
CC       growth conditions, in exponential and stationary phase. In the absence
CC       of inducer, high basal levels of activity are observed in cells growing
CC       exponentially under anaerobic conditions (at protein level)
CC       (PubMed:12193615). Strongly induced immediately after deflection from
CC       aerobic growth. {ECO:0000269|PubMed:12193615,
CC       ECO:0000269|PubMed:9785446}.
CC   -!- DISRUPTION PHENOTYPE: Non-essential, it can be deleted. Disruption
CC       suppresses alanine dehydrogenase activity, impairs the utilization of
CC       alanine as a sole nitrogen source while cells grows to a 10-fold
CC       decreased saturation density under anaerobic conditions.
CC       {ECO:0000269|PubMed:12193615}.
CC   -!- SIMILARITY: Belongs to the AlaDH/PNT family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF304867; AAM44187.1; -; Genomic_DNA.
DR   EMBL; CP000480; ABK70995.1; -; Genomic_DNA.
DR   EMBL; CP001663; AFP39064.1; -; Genomic_DNA.
DR   RefSeq; WP_003894041.1; NZ_SIJM01000064.1.
DR   RefSeq; YP_886996.1; NC_008596.1.
DR   AlphaFoldDB; A0QVQ8; -.
DR   SMR; A0QVQ8; -.
DR   STRING; 246196.MSMEI_2596; -.
DR   EnsemblBacteria; ABK70995; ABK70995; MSMEG_2659.
DR   EnsemblBacteria; AFP39064; AFP39064; MSMEI_2596.
DR   GeneID; 66734068; -.
DR   KEGG; msg:MSMEI_2596; -.
DR   KEGG; msm:MSMEG_2659; -.
DR   PATRIC; fig|246196.56.peg.2659; -.
DR   eggNOG; COG0686; Bacteria.
DR   OMA; HPYYHLY; -.
DR   OrthoDB; 673280at2; -.
DR   UniPathway; UPA00527; UER00585.
DR   Proteomes; UP000000757; Chromosome.
DR   Proteomes; UP000006158; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0000286; F:alanine dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0006524; P:alanine catabolic process; ISS:UniProtKB.
DR   GO; GO:0042853; P:L-alanine catabolic process; IEA:UniProtKB-UniPathway.
DR   CDD; cd05305; L-AlaDH; 1.
DR   InterPro; IPR008141; Ala_DH.
DR   InterPro; IPR008143; Ala_DH/PNT_CS2.
DR   InterPro; IPR008142; AlaDH/PNT_CS1.
DR   InterPro; IPR007886; AlaDH/PNT_N.
DR   InterPro; IPR007698; AlaDH/PNT_NAD(H)-bd.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   PANTHER; PTHR42795; PTHR42795; 1.
DR   Pfam; PF01262; AlaDh_PNT_C; 1.
DR   Pfam; PF05222; AlaDh_PNT_N; 1.
DR   PIRSF; PIRSF000183; Alanine_dh; 1.
DR   SMART; SM01002; AlaDh_PNT_C; 1.
DR   SMART; SM01003; AlaDh_PNT_N; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR00518; alaDH; 1.
DR   PROSITE; PS00836; ALADH_PNT_1; 1.
DR   PROSITE; PS00837; ALADH_PNT_2; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Direct protein sequencing; NAD; Nucleotide-binding;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..371
FT                   /note="Alanine dehydrogenase"
FT                   /id="PRO_0000419669"
FT   ACT_SITE        96
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P9WQB1"
FT   ACT_SITE        270
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P9WQB1"
FT   BINDING         15
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P9WQB1"
FT   BINDING         75
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P9WQB1"
FT   BINDING         134
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P9WQB1"
FT   BINDING         178..179
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P9WQB1"
FT   BINDING         198
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P9WQB1"
FT   BINDING         220
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P9WQB1"
FT   BINDING         239..240
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P9WQB1"
FT   BINDING         267..270
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P9WQB1"
FT   BINDING         279
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P9WQB1"
FT   BINDING         298..301
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:P9WQB1"
SQ   SEQUENCE   371 AA;  38955 MW;  A8010101B8EABDCF CRC64;
     MLVGIPTEIK NNEYRVAITP AGVAELTRRG HEVIIQAGAG EGSAISDRDF KAAGAEIVNT
     ADQVWSEAEL LLKVKEPIEP EYSRMRKGQT LFTYLHLAAS KPCTDALLAS GTTSIAYETV
     QTAEGALPLL APMSEVAGRL SAQVGAYHLM RSYGGRGVLM GGVPGVAPAE VVVIGAGTAG
     YNAARVAAGM GAHVTVFDLN INTLRRVDGE FGGRIETRYS SSLELEEAVK KADLVIGAVL
     VPGAKAPKLV TNSTVAHMKP GAVLVDIAID QGGCFEDSRP TTHDEPTFKV HDTIFYCVAN
     MPGAVPRTST FALTNSTMPY VLKLADKGWQ AACASDSALA KGLSTHDGKL LSEAVAKDLD
     LPFTDAAQFL A
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024